| P50 | author | Yi Liu | Q92795457 |
| P2093 | author name string | Jing Zhang | |
| | Jing Zhu | |
| | Jiang Su | |
| P2860 | cites work | TLR2 expression is regulated by microRNA miR-19 in rheumatoid fibroblast-like synoviocytes. | Q46034362 |
| | New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis | Q47104080 |
| | Ribozymes that inhibit the production of matrix metalloproteinase 1 reduce the invasiveness of rheumatoid arthritis synovial fibroblasts | Q47596891 |
| | Discoidin domain receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in synovial fibroblasts of rheumatoid arthritis | Q47882601 |
| | Rheumatoid arthritis: PIAS3 inhibition blocks FLS activity. | Q53220964 |
| | Histone Methylation and STAT-3 Differentially Regulate Interleukin-6-Induced Matrix Metalloproteinase Gene Activation in Rheumatoid Arthritis Synovial Fibroblasts. | Q53227574 |
| | MMP13mutations are the cause of recessive metaphyseal dysplasia, Spahr type | Q55115561 |
| | Rheumatoid arthritis: TNF targets histones to loosen chromatin in RA FLS | Q85361678 |
| | A novel disease-modifying antirheumatic drug, iguratimod, ameliorates murine arthritis by blocking IL-17 signaling, distinct from methotrexate and leflunomide | Q86524446 |
| | Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis | Q24598633 |
| | Rheumatoid arthritis. | Q30244019 |
| | MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients | Q33692506 |
| | Matrix Metalloproteinase Gene Activation Resulting from Disordred Epigenetic Mechanisms in Rheumatoid Arthritis. | Q33754764 |
| | Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis. | Q34077691 |
| | Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11. | Q34101406 |
| | Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. | Q34237586 |
| | The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. | Q34417592 |
| | Synovial IL-21/TNF-producing CD4+ T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast-like synoviocytes | Q34542454 |
| | MicroRNAs in rheumatoid arthritis. | Q35201337 |
| | Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis | Q35548302 |
| | Acacetin inhibits expression of matrix metalloproteinases via a MAPK-dependent mechanism in fibroblast-like synoviocytes | Q35995090 |
| | MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome | Q36322151 |
| | MRP8 promotes Th17 differentiation via upregulation of IL-6 production by fibroblast-like synoviocytes in rheumatoid arthritis | Q36809725 |
| | Apoptosis of rheumatoid arthritis fibroblast-like synoviocytes: possible roles of nitric oxide and the thioredoxin 1. | Q36831064 |
| | MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritis | Q36960767 |
| | Joint diseases and matrix metalloproteinases: a role for MMP-13. | Q37090217 |
| | The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis | Q37211275 |
| | Efficacy and safety of monoclonal antibodies targeting interleukin-17 pathway for inflammatory arthritis: a meta-analysis of randomized controlled clinical trials | Q37258941 |
| | Cell death in rheumatoid arthritis | Q37387083 |
| | Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes | Q37958543 |
| | Novel regulatory mechanisms in inflammatory arthritis: a role for microRNA. | Q37976262 |
| | Impact of microRNAs on the understanding and treatment of rheumatoid arthritis. | Q38074054 |
| | The miR-17 ∼ 92 Cluster: A Key Player in the Control of Inflammation during Rheumatoid Arthritis. | Q38091666 |
| | MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential | Q38545431 |
| | MicroRNA-143 and -145 modulate the phenotype of synovial fibroblasts in rheumatoid arthritis | Q38642200 |
| | Therapeutic effects of a novel tylophorine analog, NK-007, on collagen-induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation | Q39350335 |
| | Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice. | Q40236902 |
| | Rheumatoid arthritis synovial fibroblast and U937 macrophage/monocyte cell line interaction in cartilage degradation | Q41123982 |
| | Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes | Q42136487 |
| | CCAAT/enhancer binding protein beta mediates expression of matrix metalloproteinase 13 in human articular chondrocytes in inflammatory arthritis | Q42450124 |
| | Association of pre-miRNA-146a rs2910164 and pre‑miRNA-499 rs3746444 polymorphisms and susceptibility to rheumatoid arthritis | Q44570330 |
| P577 | publication date | 2020-01-21 | |
| P1433 | published in | Journal of Cellular Biochemistry | Q6294917 |
| P1476 | title | The promoting effect of MMP13 on mediating the development of HFLS-RA by the target of miR-19a through IL-17 signaling pathway | |